StonvexLoading…
StonvexStonvexStonvexCore line items from FN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-27 | Q4 2025 2025-12-26 | Q3 2025 2025-09-26 | Annual 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $3.33B | $2.11B | $978.13M | $3.42B |
Operating Income | $328.64M | $208.59M | $94.19M | $324.45M |
Net Income | $333.77M | $208.55M | $95.93M | $332.53M |
EPS (Diluted) | $9.22 | $5.77 | $2.66 | $9.17 |
Total Assets | $3.51B | $3.27B | $3.01B | $2.83B |
Total Liabilities | $1.20B | $1.08B | $947.60M | $849.62M |
Cash & Equivalents | $356.56M | $319.86M | $305.00M | $306.43M |
Free Cash Flow OCF − CapEx | $41.12M | $51.95M | $57.30M | $207.29M |
Shares Outstanding | 35.83M | 35.82M | 35.83M | 35.73M |